These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [The disinvestment of benzodiazepines: what aspects contributed to the decision to discontinue reimbursement?]. Rotteveel AH; Lambooij MS; de Wit GA Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34854650 [TBL] [Abstract][Full Text] [Related]
24. Identification and management of benzodiazepine dependence. Tyrer PJ; Seivewright N Postgrad Med J; 1984; 60 Suppl 2():41-6. PubMed ID: 6146970 [No Abstract] [Full Text] [Related]
25. Pharmacologic aspects of benzodiazepine tolerance and dependence. Busto U; Sellers EM J Subst Abuse Treat; 1991; 8(1-2):29-33. PubMed ID: 1675689 [TBL] [Abstract][Full Text] [Related]
26. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. Uhlenhuth EH; Balter MB; Ban TA; Yang K J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):23S-29S. PubMed ID: 10587281 [TBL] [Abstract][Full Text] [Related]
27. Benzodiazepines: tolerance and withdrawal: the clinician's point of view. Rickels K; Schweizer E; Case WG Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():102A-103A. PubMed ID: 1354016 [No Abstract] [Full Text] [Related]
28. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. Stevens JC; Pollack MH J Clin Psychiatry; 2005; 66 Suppl 2():21-7. PubMed ID: 15762816 [TBL] [Abstract][Full Text] [Related]
30. Attitudes toward benzodiazepines over the years. Rosenbaum JF J Clin Psychiatry; 2005; 66 Suppl 2():4-8. PubMed ID: 15762813 [TBL] [Abstract][Full Text] [Related]
31. Biological basis of drug-induced tolerance, rebound, and dependence. Contribution of recent research on benzodiazepines. Haefely W Pharmacopsychiatry; 1986 Sep; 19(5):353-61. PubMed ID: 2877468 [TBL] [Abstract][Full Text] [Related]
32. The natural history of tolerance to the benzodiazepines. Higgitt A; Fonagy P; Lader M Psychol Med Monogr Suppl; 1988; 13():1-55. PubMed ID: 2908516 [TBL] [Abstract][Full Text] [Related]
33. Abuse potential of benzodiazepines. Ciraulo DA Bull N Y Acad Med; 1985 Oct; 61(8):728-41. PubMed ID: 2864966 [No Abstract] [Full Text] [Related]
34. The biological basis of benzodiazepine dependence. Lader M; File S Psychol Med; 1987 Aug; 17(3):539-47. PubMed ID: 2888145 [No Abstract] [Full Text] [Related]
35. Pregabalin in the discontinuation of long-term benzodiazepines' use. Oulis P; Konstantakopoulos G; Kouzoupis AV; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kontoangelos KA; Papadimitriou GN Hum Psychopharmacol; 2008 Jun; 23(4):337-40. PubMed ID: 18348245 [TBL] [Abstract][Full Text] [Related]
36. The nosology of abuse and dependence. Kleber HD J Psychiatr Res; 1990; 24 Suppl 2():57-64. PubMed ID: 1980700 [TBL] [Abstract][Full Text] [Related]
37. Reappraising the use of benzodiazepines in chronic pain patients. Pergolizzi JV; LeQuang JA Postgrad Med; 2020 Nov; 132(sup3):10-12. PubMed ID: 32008385 [No Abstract] [Full Text] [Related]
38. [Treatment of insomnia and benzodiazepines]. Gmitrowicz A Przegl Lek; 1988; 45(10):739-42. PubMed ID: 2907664 [No Abstract] [Full Text] [Related]
39. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Lader MH Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S399-405. PubMed ID: 10622686 [TBL] [Abstract][Full Text] [Related]
40. Benzodiazepines: it's time to return to the evidence. Silberman E; Balon R; Starcevic V; Shader R; Cosci F; Fava GA; Nardi AE; Salzman C; Sonino N Br J Psychiatry; 2021 Mar; 218(3):125-127. PubMed ID: 33040746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]